Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Moderna (DE:0QF)
XETRA:0QF
Holding DE:0QF?
Track your performance easily
See the Price Targets and Ratings of:
0QF Analyst Ratings
Moderate Buy
7 Buy
10 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QF Stock 12 Month Forecast
Average Price Target
€93.84
▲(64.25% Upside)
| Highest Price Target€213.65 | Average Price Target€93.84 | Lowest Price Target€41.29 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Assigned
09/19/24
Morgan Stanley
Reiterated
09/16/24
Goldman Sachs
Reiterated
09/16/24
Barclays
Reiterated
09/16/24
Evercore ISI
Reiterated
09/13/24
Oppenheimer
Downgraded
09/13/24
J.P. Morgan
Downgraded
09/13/24
Needham
Reiterated
09/13/24
TD Cowen
Reiterated
09/13/24
Jefferies
Downgraded
09/13/24
Bank of America Securities
€116.7→€98.75
Hold
72.85%
Upside
Assigned
09/13/24
Moderna price target lowered to $110 from $130 at BofAModerna price target lowered to $110 from $130 at BofA
Brookline Capital Markets
€278.29→€213.65
Buy
273.98%
Upside
Reiterated
09/13/24
Moderna (MRNA) PT Lowered to $238 at Brookline Capital MarketsBrookline Capital Markets analyst Leah Rush Cann lowered the price target on Moderna (NASDAQ: MRNA) to $238.00 (from $310.00) while maintaining a Buy rating.
Leerink Partners
€52.07→€41.29
Sell
-27.72%
Downside
Reiterated
09/13/24
Moderna's Financial Forecast Dims: Sell Recommendation Amidst R&D and Regulatory Hurdles
Piper Sandler
€140.94→€103.24
Buy
80.70%
Upside
Reiterated
09/13/24
Moderna (MRNA) Receives a Buy from Piper Sandler
Best Analysts Covering Moderna
Which Analyst Should I Follow If I Want to Buy DE:0QF and Sell After:
1 Month
xxx
Success Rate
11/19 ratings generated profit
Average Return
+0.70%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +0.70% per trade.
3 Months
xxx
Success Rate
22/37 ratings generated profit
Average Return
-11.25%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.46% of your transactions generating a profit, with an average return of -11.25% per trade.
1 Year
Success Rate
30/37 ratings generated profit
Average Return
-12.74%
reiterated a sell rating 14 days ago
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 81.08% of your transactions generating a profit, with an average return of -12.74% per trade.
2 Years
xxx
Success Rate
34/37 ratings generated profit
Average Return
+21.89%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 91.89% of your transactions generating a profit, with an average return of +21.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QF Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
3
3
2
7
10
Buy
16
20
19
13
6
Hold
12
16
14
17
19
Sell
3
2
2
2
4
Strong Sell
1
1
1
0
0
total
35
42
38
39
39
Each month's total comprises the sum of three months' worth of ratings.
0QF Financial Forecast
0QF Stock Forecast FAQ
What is DE:0QF’s average 12-month price target, according to analysts?
Based on analyst ratings, Moderna’s 12-month average price target is €93.84.
What is DE:0QF’s upside potential, based on the analysts’ average price target?
Moderna has 64.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Moderna a Buy, Sell or Hold?
Moderna has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 10 hold ratings and 2 sell ratings.
What is Moderna’s share price target?
The average share price target for Moderna is €93.84. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €213.65 ,and the lowest forecast is €41.29. The average share price target represents 64.25% Increase from the current price of €57.13.
The highest analyst share price target is €213.65 ,and the lowest forecast is €41.29. The average share price target represents 64.25% Increase from the current price of €57.13.
What do analysts say about Moderna?
Moderna’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of Moderna?
To buy shares of DE:0QF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.